Skip to main content
Contact Us
Subscribe
E-Edition
85°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Archives
Best of 2025
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about Biogen Inc
Recent news which mentions Biogen Inc
< Previous
1
2
3
4
Next >
5 things to know before the stock market opens Tuesday
July 18, 2023
Tags
Bank of America Corp
Economy
Technology
From
CNBC.com News
Eli Lilly expects FDA decision on Alzheimer's treatment donanemab by the end of the year
July 17, 2023
Tags
Health care industry
Biotechnology
Alzheimer's disease
From
CNBC.com News
Medicare will pay for Alzheimer's drug Leqembi. What patients and doctors should know
July 08, 2023
Tags
Business
Politics
Eisai Co Ltd
From
CNBC.com News
Sales of Alzheimer’s drug Leqembi may be slow initially but could pick up in 2024
July 07, 2023
Tags
US: News
Pharmaceuticals
Business News
From
CNBC.com News
Stocks making the biggest moves midday: Rivian, Levi Strauss, Biogen, First Solar and more
July 07, 2023
Tags
Alibaba Group Holding Ltd
Levi Strauss & Co
TG Therapeutics Inc
From
CNBC.com News
Stocks making the biggest premarket moves: Levi Strauss, Biogen, Alibaba and more
July 07, 2023
Tags
Biogen Inc
First Solar Inc
Meta Platforms Inc
From
CNBC.com News
Japanese pharma Eisai slides 4% despite FDA approval for Alzheimer's drug
July 07, 2023
Tags
Pharmaceuticals
Asia Markets
Social issues
From
CNBC.com News
FDA approves Alzheimer’s drug Leqembi, paving way for broader Medicare coverage
July 06, 2023
Tags
Business News
US: News
Alzheimer's disease
From
CNBC.com News
Stocks making the biggest moves midday: JD.Com, Biogen, Oracle and more
June 13, 2023
Tags
Freeport/McMoRan Inc
Goldman Sachs BDC Inc
Royal Caribbean Cruises Ltd
From
CNBC.com News
FDA advisors to weigh whether Alzheimer's drug Leqembi should receive full approval
June 09, 2023
Tags
Biogen Inc
US: News
Disease outbreaks
From
CNBC.com News
Bernie Sanders says price of Alzheimer's treatment is unconscionable, calls on HHS to take action
June 07, 2023
Tags
US: News
U/S/ Economy
Business News
From
CNBC.com News
Jim Cramer expects defensive stocks to be resilient as debt ceiling talks drag on
May 15, 2023
Tags
Food and Beverage
Business News
stocks
From
CNBC.com News
Alzheimer's treatment Leqembi could cost Medicare up to $5 billion per year, study estimates
May 12, 2023
Tags
Health & Science
Eli Lilly and Co
Business
From
CNBC.com News
Stocks making the biggest moves premarket: Starbucks, AMD, Pearson, PacWest & more
May 03, 2023
Tags
Cogent Communications Holdings Inc
Biogen Inc
Match Group Inc
From
CNBC.com News
Bipartisan attorneys general call on Medicare to cover Alzheimer's treatments
May 01, 2023
Tags
Business
Eisai Co Ltd
Politics
From
CNBC.com News
Alzheimer’s patients may wait years to get treated with new drugs, putting them at risk of more severe disease
April 30, 2023
Tags
Biogen Inc
Breaking News: Business
Biotechnology
From
CNBC.com News
Alzheimer's: Medicare will cover Leqembi for all patients if FDA approves drug, CMS chief says
April 26, 2023
Tags
Policy
Epidemics
Biotech and Pharmaceuticals
From
CNBC.com News
Biogen isn't concerned about competing with Eli Lilly in the Alzheimer’s drug space, CEO says
April 25, 2023
Tags
Breaking news
Health & Science
Companies
From
CNBC.com News
FDA grants accelerated approval for Biogen ALS drug that treats rare form of the disease
April 25, 2023
Tags
Science
Biotech and Pharmaceuticals
Drug approvals
From
CNBC.com News
Alzheimer’s patients retain the benefits of Leqembi even when they stop the drug, Eisai says
April 06, 2023
Tags
Science
Biotech and Pharmaceuticals
Eli Lilly and Co
From
CNBC.com News
Eli Lilly says experimental Alzheimer's drug reduces brain plaque in early study
April 05, 2023
Tags
Biotech and Pharmaceuticals
Science
Eisai Co Ltd
From
CNBC.com News
FDA advisors reject Biogen's ALS drug for rare and aggressive form of the disease
March 22, 2023
Tags
Biogen Inc
Biotech and Pharmaceuticals
Breaking News: Business
From
CNBC.com News
FDA staff says Biogen's ALS drug may have a 'clinical benefit' on a rare form of the disease
March 20, 2023
Tags
Biotech and Pharmaceuticals
Biogen Inc
Business
From
CNBC.com News
Veterans' Health will cover Alzheimer's treatment Leqembi for some patients
March 13, 2023
Tags
World News
US Top News and Analysis
Coronavirus
From
CNBC.com News
FDA will review Eisai's and Biogen's Alzheimer's treatment Leqembi with decision on full approval expected in early July
March 06, 2023
Tags
Health care industry
Biotechnology
Breaking News: Business
From
CNBC.com News
Medicare rejects Alzheimer's Association request for unrestricted coverage of treatments like Leqembi
February 23, 2023
Tags
Politics
Eisai Co Ltd
Business
From
CNBC.com News
Stocks making the biggest moves midday: Deere, Airbnb, AutoNation, Moderna and more
February 17, 2023
Tags
Business
Market Insider
Zebra Technologies Corp
From
CNBC.com News
Senators call on Medicare to offer broad coverage of Alzheimer's treatments as public pressure grows
February 17, 2023
Tags
US Economy
Health & Science
Coronavirus
From
CNBC.com News
Maker of promising Alzheimer's drug Leqembi expects full FDA approval this summer, expanded Medicare coverage
February 17, 2023
Tags
Biogen Inc
U/S/ Economy
Business News
From
CNBC.com News
Stocks making the biggest moves premarket: Kraft Heinz, Paramount, Airbnb, Tripadvisor and more
February 15, 2023
Tags
Breaking news
Taiwan Semiconductor Manufacturing Co Ltd
Airbnb Inc
From
CNBC.com News
< Previous
1
2
3
4
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.